Diprophos and Celestan
Recall
|
Medicines
|
27/01/2023
The marketing authorisation holder informed its customers on January 27, 2023, that the two medicinal products may contain stainless steel particles originating from the manufacturing process. For this reason, the mentioned batches are recalled as a precautionary measure.
| Name of the medicinal product | 1) Diprophos 1 ml - Suspension zur Injektion 2) Diprophos 2 ml - Suspension zur Injektion 3) Celestan biphase 5,7 mg/ml Injektionssuspension |
|---|---|
| Marketing authorisation number(s) | 1) 16.460 2) 16.848 3) 14.257 |
| CIP code | 1) 0522709, 0522715 2) 0614601 3) 0068481, 0519742 |
| Marketing authorisation holder | Organon Healthcare GmbH |
| Batch number(s) | 1) Batch, Expiry Date U037460, 31.08.2023 W026238, 30.06.2024 W035588, 31.07.2024 U034875, 31.07.2023 U038303, 31.08.2023 W001818, 30.09.2023 W010963, 31.12.2023 W025260, 31.05.2024 W030260, 31.07.2024 2) Batch, Expiry Date U038056, 30.09.2023 W004349, 31.10.2023 W020084, 31.03.2024 3) Batch, Expiry Date W005316, 30.04.2023 W001817, 30.04.2023 W005637, 31.05.2023 W014708, 31.07.2023 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4172 |
Further inquiry note
Page last modified:
27/01/2023